ConductScience.org, home

Trial · NCT02478359

Walk On! Physical Activity Coaching

NCT02478359, Not applicable, Completed, Kaiser Permanente; results first posted 2020-02-19

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Walk On! Physical Activity Coaching. Trials, record NCT02478359. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02478359

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Walk On! Physical Activity Coaching
NCT number
NCT02478359
Status
Completed
Phases
Not applicable
Enrollment
2,707 participants, actual
Lead sponsor
Kaiser Permanente
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
Physical Activity Coaching (Walk On!)
First posted
2015-06-23
Last updated
2020-02-19
Results first posted
2020-02-19
Limitations and caveats
It is important to note the low uptake/participation in the Walk On! intervention and its effects on the primary, intention to treat analyses, as well, the sub-optimal baseline and follow-up response rates to the patient-reported outcomes.

Source ClinicalTrials.gov

Registered outcomes34

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Deaths Among Participants12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Participants With All-cause Hospitalizations12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Participants With All-cause Emergency Department Visits12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Participants With All-cause Observation Stays12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays12 months following randomization
Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site
SecondaryNumber of Participants With COPD Exacerbation12 months following randomization
COPD exacerbations were ascertained via pharmacy records and utilization data. An outpatient COPD exacerbation will be defined as a care touch (clinic visit, phone, or secure message encounter) with a diagnosis of COPD accompanied by a prescription of either an oral steroid or an antibiotic within 2 days
SecondaryCOPD Assessment Test, CAT - 12 Months12 months
The reported mean change between the baseline and 12 Months scores for the Chronic Obstructive Pulmonary Disease Assessment Test (CAT). Score range is 0-40. A negative change score indicates fewer symptoms.
SecondaryPhysical Activity12 months
Patients were categorized as being: completely inactive (0 mins/week), insufficiently active (1-149 mins/week) or active, meeting national physical activity recommendations (\>150 mins/week) of moderate to vigorous physical activity.
SecondaryPersonal Health Questionnaire, PHQ8 - 12 Months12 monthsThe reported mean change between the baseline and 12 Months scores. Score range is 0-24. A negative change score indicates less depressive symptoms.

Outcomes34

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Deaths Among Participants12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Hospitalizations12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Emergency Department Visits12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With All-cause Observation Stays12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays12 months following randomizationITT PopulationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With COPD Exacerbation12 months following randomizationITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCOPD Assessment Test, CAT - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN
SECONDARYPhysical Activity12 monthsITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPersonal Health Questionnaire, PHQ8 - 12 Months12 monthsAs treated population who completed the surveyscore on a scaleMEAN

Results by group98

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and DeathsStandard Care864Participants
Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and DeathsPhysical Activity Coaching (Walk On!)883Participants
Number of Deaths Among ParticipantsStandard Care117Participants
Number of Deaths Among ParticipantsPhysical Activity Coaching (Walk On!)117Participants
Number of Participants With All-cause HospitalizationsStandard Care499Participants
Number of Participants With All-cause HospitalizationsPhysical Activity Coaching (Walk On!)502Participants
Number of Participants With All-cause Emergency Department VisitsStandard Care694Participants
Number of Participants With All-cause Emergency Department VisitsPhysical Activity Coaching (Walk On!)702Participants
Number of Participants With All-cause Observation StaysStandard Care269Participants
Number of Participants With All-cause Observation StaysPhysical Activity Coaching (Walk On!)295Participants

Participant flow8

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDStandard Care1,349
Overall StudySTARTEDPhysical Activity Coaching (Walk On!)1,358
Overall StudyIntention-to-treat Population Month 12Standard Care1,243
Overall StudyIntention-to-treat Population Month 12Physical Activity Coaching (Walk On!)1,293
Overall StudyCOMPLETEDStandard Care1,243
Overall StudyCOMPLETEDPhysical Activity Coaching (Walk On!)1,293
Overall StudyNOT COMPLETEDStandard Care106
Overall StudyNOT COMPLETEDPhysical Activity Coaching (Walk On!)65

Adverse events6

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherObservational StaysInvestigationsStandard Care2691,349269
otherObservational StaysInvestigationsPhysical Activity Coaching (Walk On!)2951,358295
otherEmergency Department VisitsInvestigationsStandard Care6941,349694
otherEmergency Department VisitsInvestigationsPhysical Activity Coaching (Walk On!)7021,358702
seriousAll-cause hospitalizationsInvestigationsStandard Care4991,349499
seriousAll-cause hospitalizationsInvestigationsPhysical Activity Coaching (Walk On!)5021,358502

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityStandard Care1171,349
Total, all-cause mortalityPhysical Activity Coaching (Walk On!)1171,358
Total, other adverse eventsStandard Care9631,349
Total, other adverse eventsPhysical Activity Coaching (Walk On!)9971,358
Total, serious adverse eventsStandard Care4991,349
Total, serious adverse eventsPhysical Activity Coaching (Walk On!)5021,358

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
26597414BACKGROUNDPubMed
30144938BACKGROUNDPubMed
31418811DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons15

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Observation StaysTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause HospitalizationsTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and DeathsTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With COPD ExacerbationTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Observation StaysTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Emergency Department VisitsTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause HospitalizationsTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Emergency Department VisitsTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With COPD-Related Hospitalizations, ED Visits, and Observation StaysTrial comparisons
Physical Activity Coaching (Walk On!) vs Standard Care: Number of Deaths Among ParticipantsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02478359

GET https://conductscience.org/api/trials/v1/NCT02478359/registered?page=2